MDT

97.71

-2.09%↓

148.59

+1.08%↑

VEEV

241.39

-0.83%↓

HQY

95.25

-2.39%↓

PHR.US

17.19

+1.9%↑

MDT

97.71

-2.09%↓

148.59

+1.08%↑

VEEV

241.39

-0.83%↓

HQY

95.25

-2.39%↓

PHR.US

17.19

+1.9%↑

MDT

97.71

-2.09%↓

148.59

+1.08%↑

VEEV

241.39

-0.83%↓

HQY

95.25

-2.39%↓

PHR.US

17.19

+1.9%↑

MDT

97.71

-2.09%↓

148.59

+1.08%↑

VEEV

241.39

-0.83%↓

HQY

95.25

-2.39%↓

PHR.US

17.19

+1.9%↑

MDT

97.71

-2.09%↓

148.59

+1.08%↑

VEEV

241.39

-0.83%↓

HQY

95.25

-2.39%↓

PHR.US

17.19

+1.9%↑

Home・Akcijų sąrašas・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

37.98 1.47

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

36.79

Max

37.85

Pagrindiniai rodikliai
By Trading Economics
Pajamos	11M 51M
Pardavimai	39M 239M
P/E Sektoriaus vid.	11.593 87.826
Pelnas, tenkantis vienai akcijai	1.08
Pelno marža	21.242
Darbuotojai	268
EBITDA	14M 73M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+16.72% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-02-24

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	429M 2.1B
Ankstesnė atidarymo kaina	36.51
Ankstesnė uždarymo kaina	37.98

Naujienos nuotaikos

By Acuity

34%

66%

111 / 372 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

29.8 / N/A Palaikymas ir pasipriešinimas

Harmony Biosciences Holdings Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-01-08 23:08; UTC

Įsigijimai, susijungimai, perėmimai

Rio Tinto, Glencore in Talks to Form World's Biggest Miner -- 3rd Update

2026-01-08 21:39; UTC

Įsigijimai, susijungimai, perėmimai

Glencore, Rio Tinto Restart Merger Talks -- 2nd Update

2026-01-08 20:54; UTC

Įsigijimai, susijungimai, perėmimai

Glencore, Rio Tinto Restart Merger Talks -- Update

2026-01-08 20:44; UTC

Įsigijimai, susijungimai, perėmimai

Glencore, Rio Tinto Restart Merger Talks

2026-01-08 17:05; UTC

Įsigijimai, susijungimai, perėmimai

Chinese Anta Sports Products Offers to Buy Pinault Family's Stake in Puma, Reuters Says, Citing Unnamed Sources

2026-01-08 16:43; UTC

Pagrindinės rinkos jėgos

Babcock & Wilcox Shares Rise on Siemens Deal for Data Center Project

2026-01-08 23:44; UTC

Rinkos pokalbiai

Nikkei May Rise on Weaker Yen -- Market Talk

2026-01-08 23:37; UTC

Rinkos pokalbiai

Gold Steady, Underpinned by Geopolitical Risks -- Market Talk

2026-01-08 22:42; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-01-08 22:42; UTC

Rinkos pokalbiai

RBA Still Battling a Troubling Inflation Outlook, Says TD -- Market Talk

2026-01-08 22:30; UTC

Įsigijimai, susijungimai, perėmimai

Glencore, Rio Tinto Confirm Early Merger Talks -- Barrons.com

2026-01-08 21:53; UTC

Uždarbis

These Stocks Moved the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

2026-01-08 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-01-08 21:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2026-01-08 21:10; UTC

Įsigijimai, susijungimai, perėmimai

Rio Tinto Says Current Expectation That Any Deal Would Involve Buying Glencore Via Scheme of Arrangement

2026-01-08 21:09; UTC

Rinkos pokalbiai

Oil Rises As Trump Said to Back Russia Sanctions Bill -- Market Talk

2026-01-08 21:09; UTC

Įsigijimai, susijungimai, perėmimai

Rio Tinto Confirms in Talks With Glencore Over Possible Merger

2026-01-08 20:21; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Down Despite Inventory Draw -- Market Talk

2026-01-08 19:44; UTC

Rinkos pokalbiai

Gold's Shine Masks Deep Drops in Canada Steel, Aluminum Exports -- Market Talk

2026-01-08 18:50; UTC

Rinkos pokalbiai

Mexico's Industrial Production Seen Lower in November -- Market Talk

2026-01-08 17:48; UTC

Uždarbis

These Stocks Are Moving the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

2026-01-08 17:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-01-08 17:20; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2026-01-08 17:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-01-08 17:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2026-01-08 16:45; UTC

Rinkos pokalbiai

Goldman Lifts 1H LME Copper Forecast -- Market Talk

2026-01-08 16:03; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-01-08 16:03; UTC

Rinkos pokalbiai

Currency Markets Could Be Underpricing Medium-Term Risks -- Market Talk

2026-01-08 16:02; UTC

Rinkos pokalbiai

U.S. Natural Gas Inventories Fall As Expected -- Market Talk

2026-01-08 15:23; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Defends Its Hostile Bid for Warner -- Update

Akcijų palyginimas

Kainos pokytis

Harmony Biosciences Holdings Inc Prognozė

Kainos tikslas

By TipRanks

16.72% į viršų

12 mėnesių prognozė

Vidutinis 43.83 USD 16.72%

Aukščiausias 55 USD

Žemiausias 32 USD

Remiantis 6 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Harmony Biosciences Holdings Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

6 ratings

Pirkti

Laikyti

Parduoti

Remiantis 6 analitikų, pateikusių Harmony Biosciences Holdings Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

29.8 / N/APalaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Rinkos nuotaikos

By Acuity

111 / 372 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.